Vertex Pharmaceutials

Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group
Yahoo/Reuters
Thu, 04/13/23 - 10:01 am
Vertex Pharmaceutials
CRISPR Therapeutics
gene therapy
sickle cell disease
ICER
Earnings Preview: Biotechnology Looks Healthy
Barron's
Sat, 04/8/17 - 12:52 pm
earnings
biotech
Amgen
Celgene
Vertex Pharmaceutials
Biogen
Akorn